Company / Working Capital
Outlook Therapeutics, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$28.4M
FY2025
5-year range
-$28.7M / $2.1M
FY2021-FY2025
Trend
-1483.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed -1483% YoY in FY2025, a notable deviation from the 5-year average annual change of -272%.
Based on SEC 10-K filings.
-$28M in FY2025.
Declined from -$7M to -$28M over the past 6 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 1483.2% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$28.4M | -1483.2% |
| FY2020 | $2.1M | +130.3% |
| FY2019 | -$6.8M | +76.4% |
| FY2018 | -$28.7M | -15.7% |
| FY2017 | -$24.8M | -68.3% |
| FY2016 | -$14.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026